Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The Placing Shares will represent approximately 14.65 per cent. of the Company's enlarged issued ordinary share capital. The new Ordinary Shares will be fully paid and will rank pari passu in all respects with the existing Ordinary Shares. Following completion of the Placing, the total issued share capital of the Company will comprise 620,392,695 ordinary shares of nil par value each. Operational update The Company has continued to make excellent progress and in March 2014 reached a total of over 30 million daily unique users and is now deployed across nine ISPs. Related party transactions Pursuant to the Placing, Meditor European Master Fund Limited ("Meditor") and Viollette Company Limited ("Viollette") will each be investing £1.4 million in Placing Shares. These subscriptions for Placing Shares will result in Meditor and Viollette being interested, in aggregate, in 210,596,786 Ordinary Shares and 221,672,251 Ordinary Shares respectively, representing approximately 33.95 per cent. and 35.73 per cent. respectively of the Company's enlarged issued ordinary share capital on completion of the Placing. In the event that both Meditor and Viollette were to convert in full their pre-existing holdings of, in aggregate, £1.95m of secured convertible loan notes issued in April 2013, and taking into account their planned participations in the Placing, their shareholdings in the Company would increase to 34.93 per cent. and 36.61 per cent. respectively. Solely by virtue of Meditor and Viollette currently being substantial shareholders in the Company, Meditor's and Viollette's respective subscriptions for Placing Shares constitute related party transactions for the purposes of Rule 13 of the AIM Rules for Companies. In light of the above, the directors of Phorm consider, having consulted with Strand Hanson Limited (the Company's Nominated Adviser), that the terms of Meditor's and Viollette's participations in the Placing are fair and reasonable insofar as the Company's shareholders are concerned. The abovementioned participation of Viollette in the Placing is currently subject to the receipt of certain limited internal investment approvals of a routine nature. In the event that such anticipated approvals are not forthcoming, the Company and its broker, Mirabaud Securities, would seek to procure an alternative placee(s) and/or scale back the size of the Placing and a further announcement would be made as appropriate.
will be fully paid and will rank pari passu in all respects with the existing Ordinary Shares. Following completion of the Placing, the total issued share capital of the Company will comprise 620,392,695 ordinary shares of nil par value each. Operational update The Company has continued to make excellent progress and in March 2014 reached a total of over 30 million daily unique users and is now deployed across nine ISPs. Related party transactions Pursuant to the Placing, Meditor European Master Fund Limited ("Meditor") and Viollette Company Limited ("Viollette") will each be investing £1.4 million in Placing Shares. These subscriptions for Placing Shares will result in Meditor and Viollette being interested, in aggregate, in 210,596,786 Ordinary Shares and 221,672,251 Ordinary Shares respectively, representing approximately 33.95 per cent. and 35.73 per cent. respectively of the Company's enlarged issued ordinary share capital on completion of the Placing. In the event that both Meditor and Viollette were to convert in full their pre-existing holdings of, in aggregate, £1.95m of secured convertible loan notes issued in April 2013, and taking into account their planned participations in the Placing, their shareholdings in the Company would increase to 34.93 per cent. and 36.61 per cent. respectively. Solely by virtue of Meditor and Viollette currently being substantial shareholders in the Company, Meditor's and Viollette's respective subscriptions for Placing Shares constitute related party transactions for the purposes of Rule 13 of the AIM Rules for Companies. In light of the above, the directors of Phorm consider, having consulted with Strand Hanson Limited (the Company's Nominated Adviser), that the terms of Meditor's and Viollette's participations in the Placing are fair and reasonable insofar as the Company's shareholders are concerned. The abovementioned participation of Viollette in the Placing is currently subject to the receipt of certain limited internal investment approvals of a routine nature. In the event that such anticipated approvals are not forthcoming, the Company and its broker, Mirabaud Securities, would seek to procure an alternative placee(s) and/or scale back the size of the Placing and a further announcement would be made as appropriate.
Phorm Corporation Limited ("Phorm" or the "Company") Proposed Placing to raise approximately £10 million gross Operational Update and Notice of Extraordinary General Meeting Over 30 million daily unique users across nine ISPs Phorm (AIM: PHRM), a leading internet personalisation technology company, announces, further to its announcement of yesterday, that it has today conditionally placed via Mirabaud Securities LLP ("Mirabaud Securities"), in aggregate, 90,909,000 new ordinary shares of nil par value each in the capital of the Company (the "Placing Shares"), with certain new and existing institutional and other investors, at a price of 11 pence per share (the "Placing Price") to raise approximately £10 million before expenses (the "Placing"). Phorm intends to use the net proceeds raised from the Placing for the Group's general working capital purposes. Details of the Placing The Placing is conditional, inter alia, upon: - the passing of the necessary resolutions to give authority to the Phorm Directors to allot and issue the Placing Shares at an extraordinary general meeting to be convened at the offices of Hogan Lovells International LLP, Atlantic House, Holborn Viaduct, London EC1A 2FG, United Kingdom at 12 noon (London time) on 14 April 2014; and - admission of the Placing Shares to trading on the AIM market operated by the London Stock Exchange plc ("AIM"). The Placing Shares have been conditionally placed by Mirabaud Securities, as agent of the Company, with certain existing and new institutional and other investors pursuant to the Placing Agreement. Under the terms of the Placing Agreement, Mirabaud Securities will receive commission from the Company conditional on Admission and the Company will give customary warranties and undertakings to Mirabaud Securities in relation, inter alia, to its business and the performance of its duties. In addition, the Company has agreed to indemnify Mirabaud Securities in relation to certain liabilities that it may incur in undertaking the Placing. Mirabaud Securities has the right to terminate the Placing Agreement in certain circumstances prior to Admission, in particular, in the event that there has been, inter alia, a material breach of any of the warranties. The Placing is not being underwritten. The mid-market price of an Ordinary Share at the close of business on 26 March 2014 (being the latest practicable date prior to this announcement) was 11 pence. Application will be made to the London Stock Exchange for admission of the Placing Shares to trading on AIM ("Admission"). It is expected that Admission will become effective and that dealings in the Placing Shares will commence at 8.00 a.m. on 15 April 2014. The Placing Shares will represent approximately 14.65 per cent. of the Company's enlarged issued ordinary share capital. The new Ordinary Shares will be f
Out equity and egm
Couldn't find anyone willing to underwrite the issue?
10m to be raised
Is PHRM any near to turning a corner?
http://www.shanghaidaily.com/article/article_xinhua.aspx?id=206783 Mar 15,2014 Quote:- BEIJING, March 15 (Xinhua) -- Industrial standards for China's Internet advertising went into effect on Saturday as concerns rise over users' information security. The standards, created by the China Internet Association, require that the collection, use, transfer and sharing of user information should stick to mutual agreements and abide by laws and regulations. Websites are required to make clear to users when they are collecting and using information and notify users in a timely manner for privacy protection. Sensitive information can only be collected after agreement by users, according to the standards.
They have in the past raised money in the markets way above the share price. With the MOU with China Telecom and favourable market conditions, will the same happen again. Intriguing! tpp
Usually c. £10M worth. The higher the share price, the fewer they need to issue, which is why they always try to boost the price just before a share issue.
...according to LSE, III, etc, but perhaps you know better?
Keep up John boy! tpp
China Telecom Corporation Limited is an integrated information full services operator and the world's largest wireline telecommunications, CDMA mobile network and broadband Internet services provider, providing basic telecommunications services such as wireline telecommunications services and mobile telecommunications services, and value-added telecommunications services such as internet access services and information services in the PRC. As at January 2014, the company had wireline access lines in service of approximately 155 million, wireline broadband subscribers of approximately 100 million and mobile subscribers of approximately 185 million
Rise now down to 8.89% as I type
Shares in internet technology specialist Phorm Corporation (LON:PHRM) shot up as it unveiled a three-year tie-up with China Telecom, the state-owned telecom giant. The deal sees the firm become China's preferred strategic partner in the field of 'Big Data' and advertising operations. “This agreement further reinforces the progress that the company has made since the launch of its commercial operations with three Internet Service Providers (ISPs) in the People's Republic of China,” Phorm said. “Phorm is continuing to build its commercial operations and expects to launch with further ISPs in China later this year.” Shares gained 12% to stand at 12.65p. It was a closely followed tale, with heavy volumes of the shares changing hands on Monday morning on the back of the news
Alliance News Phorm shares up 19% As It Inks Agreement With China Telecom Mon, 10th Mar 2014 11:46 LONDON (Alliance News) - Shares in Phorm Corporation Ltd rose 19% Monday after it said it had inked a memorandum of understanding with China Telecom Corporation Ltd to become its strategic partner for 'Big Data' and advertising. Phorm operates an opt-in online advertising platform that protects users privacy whilst making content and advertising more relevant to them. The three-year agreement covers a wide-range of proposed initiatives, Phorm said. "Phorm is delighted to have been selected to become China Telecom's preferred strategic partner, not only for advertising, but also for its 'Big Data' initiatives and looks forward to continuing to work closely with China Telecom on a range of innovative products and services," the company said in a statement. Phorm launched its commercial operations in China in January. It expects to launch its service with further internet service providers in China later this year. China Telecom, a state-owned telecommunications company, has operations in 31 provinces and over 100 million broadband customers, Phorm said. Shares in Phorm were trading up 19% at 13.33 pence Monday morning.
How many more shares would they Issue?,,,,,,this time round,,,
Roughly every three months.
Any one know,,when does Phorm Run Out Of Money?
Sometimes you have to put aside your opinions and view a share just on trading grounds.. so reinvested first thing as I can see 15p here today/tomorrow - then I will be back out. A placing is due soon but another operations update might be first. Phorm has always been an interesting share and still not convinced that China will be any different to previous countries gla
shes gonna blow
never known a salesman yet who earned a bean of commission from a MOU. And as for preferred strategic partner, well, if it was sole strategic partner... Not bad news, but hardly earth shattering.
More like a 'yawn - heard it all before' response.
Look like not many have noticed these Rns.
RNS Number : 8775B Phorm Corporation Limited 10 March 2014 10 March 2014 Phorm Corporation Limited ("Phorm" or the "Company") Memorandum of Understanding signed with China Telecom Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce that it has signed a Memorandum of Understanding ("MoU") with China Telecom Corporation Limited ("China Telecom") and certain of its associated group entities to become its preferred strategic partner in the field of 'Big Data' technology and advertising operations. Highlights: · Memorandum of Understanding is valid for three years · Establishes Phorm as China Telecom's strategic partner for 'Big Data' and advertising · Agreement covers a wide-range of proposed initiatives · Reinforces Phorm's continued progress in China Phorm has signed a three year MoU with China Telecom, the world's largest wireline telecommunications, code division multiple access (CDMA) mobile network and broadband Internet services provider. This agreement further reinforces the progress that the Company has made since the launch of its commercial operations with three Internet Service Providers ("ISPs") in the People's Republic of China as announced on 27 January 2014. Phorm is continuing to build its commercial operations and expects to launch with further ISPs in China later this year. The China Telecom group has operations in 31 Chinese provinces and over 100 million broadband customers. Phorm is delighted to have been selected to become China Telecom's preferred strategic partner, not only for advertising, but also for its 'Big Data' initiatives and looks forward to continuing to work closely with China Telecom on a range of innovative products and services. -Ends- For further information please contact: Phorm Corporation Limited Andy Croxson (analysts and investors) +44 (0) 203 397 6001 UK Investors Mirabaud Securities LLP +44 20 7321 2508 (Broker) Jason Woollard Peter Krens Strand Hanson Limited +44 20 7409 3494 (Nominated Adviser) James Harris Matthew Chandler James Dance US Investors Lippert/Heilshorn and Associates +1 212 838 3777 (Investor Relations) John Heilshorn About Phorm Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users. Phorm's advertising platform revolutionises current standards of online privacy, fully protecting t